Oppenheimer Asset Management Inc. Buys 1,659 Shares of HCA Healthcare, Inc. $HCA

Oppenheimer Asset Management Inc. boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 39.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 5,813 shares of the company’s stock after acquiring an additional 1,659 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in HCA Healthcare were worth $2,478,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of HCA. Fielder Capital Group LLC purchased a new stake in HCA Healthcare in the 3rd quarter valued at about $212,000. Smartleaf Asset Management LLC grew its stake in HCA Healthcare by 36.4% in the third quarter. Smartleaf Asset Management LLC now owns 3,203 shares of the company’s stock worth $1,349,000 after purchasing an additional 855 shares in the last quarter. Canada Post Corp Registered Pension Plan raised its position in HCA Healthcare by 224.7% during the 3rd quarter. Canada Post Corp Registered Pension Plan now owns 10,406 shares of the company’s stock valued at $4,380,000 after purchasing an additional 7,201 shares in the last quarter. Twin Capital Management Inc. increased its stake in shares of HCA Healthcare by 31.4% during the third quarter. Twin Capital Management Inc. now owns 950 shares of the company’s stock valued at $405,000 after buying an additional 227 shares during the period. Finally, Bessemer Group Inc. lifted its stake in HCA Healthcare by 19.0% in the third quarter. Bessemer Group Inc. now owns 3,364 shares of the company’s stock worth $1,434,000 after acquiring an additional 536 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HCA shares. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. Royal Bank Of Canada lifted their price target on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Stephens raised their price objective on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Oppenheimer increased their price target on shares of HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Finally, Jefferies Financial Group increased their target price on shares of HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised FY-2026 EPS to $29.31 (from $28.47) and lifted multiple quarterly and multi‑year estimates (FY2027 to $33.44, FY2028 to $37.67), aligning analyst expectations with HCA’s FY2026 guidance and suggesting stronger forward profitability. Zacks remains at a “Hold” rating, but the higher estimates support valuation and earnings momentum. Zacks estimate changes (MarketBeat)
• Neutral Sentiment: HCA’s StoneSprings Hospital Center is planning to convert a Chantilly deli site into a freestanding emergency room — a local expansion that could modestly increase patient volumes and admissions in that market over time. HCA StoneSprings freestanding ER
• Neutral Sentiment: HCA-related ASC real estate was sold, a move that can free capital or change lease/operating dynamics for ambulatory surgery centers; the net effect depends on deal terms and use of proceeds. HCA ASC real estate sold
• Neutral Sentiment: Executive moves: a former HCA Florida executive joined Memorial Health as COO and an HCA veteran was named COO at Memorial Health in Georgia — routine industry leadership turnover that may have limited near‑term impact on HCA’s financials but is notable for regional competitive dynamics and management talent flow. Former HCA exec joins Memorial Health (MSN) HCA veteran named COO (Becker’s)

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 13,520 shares of company stock worth $6,894,067 in the last three months. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.7%

NYSE:HCA opened at $535.24 on Friday. The company’s 50 day moving average is $481.73 and its two-hundred day moving average is $446.85. The company has a market cap of $119.69 billion, a PE ratio of 18.86, a P/E/G ratio of 1.63 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $552.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is currently 10.15%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.